0001209191-21-047616.txt : 20210721 0001209191-21-047616.hdr.sgml : 20210721 20210721185424 ACCESSION NUMBER: 0001209191-21-047616 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210719 FILED AS OF DATE: 20210721 DATE AS OF CHANGE: 20210721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Toernsen Monika Maria CENTRAL INDEX KEY: 0001873385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39231 FILM NUMBER: 211105563 MAIL ADDRESS: STREET 1: ONE COMMERCE SQUARE STREET 2: 2005 MARKET STREET, 39TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Passage BIO, Inc. CENTRAL INDEX KEY: 0001787297 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822729751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE COMMERCE SQUARE STREET 2: 2005 MARKET STREET, 39TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 2678660312 MAIL ADDRESS: STREET 1: ONE COMMERCE SQUARE STREET 2: 2005 MARKET STREET, 39TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-19 0 0001787297 Passage BIO, Inc. PASG 0001873385 Toernsen Monika Maria ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 0 1 0 0 Chief Commercial Officer Employee Stock Option (Right to Buy) 13.04 2021-07-19 4 A 0 200000 0.00 A 2031-07-18 Common Stock 200000 200000 D Restricted Stock Units 2021-07-19 4 A 0 20000 0.00 A Common Stock 20000 20000 D The option vests as to 25% of the total shares on July 19, 2022, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on July 19, 2024, subject to the Reporting Person's provision of service to the issuer on each vesting date. Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. 1/4 of the RSUs will vest annually on September 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date. /s/ Edgar Cale, Attorney-in-Fact 2021-07-21